In experimental autoimmune encephalomyelitis (EAE), a neuroinflammatory animal model for MS, the pan PDE4 inhibitor rolipram (2 mg/kg, i.p injected twice a day) modified the cerebrovascular endothelial permeability and thereby restored BBB function (48). Here, PDE4A is linked to myeloid sarcoma.